Medovex Corporation (NASDAQ:MDVX) reached 7.89% versus a 1-year low price of $1. The stock was last seen -13.69% lower, reaching at $1.08 on May 24, 2017. At recent session, the prices were hovering between $1.05 and $1.2268. This company shares are -100% up from its target price of $0 and the current market capitalization stands at $20.01M. The recent change has given its price a -20.66% deficit over SMA 50 and -56.5% deficit over its 52-week high. The stock witnessed -20.08% declines, -8.57% declines and -26.1% declines for the 1-month, 3-month and 6-month period, respectively. To measure price-variation, we found MDVX’s volatility during a week at 9.96% and during a month it has been found around 8.6%.

Medovex Corporation 13F Filings

At the end of March 2017 reporting period, 5 institutional holders increased their position in Medovex Corporation (NASDAQ:MDVX) by some 22,124 shares, 6 decreased positions by 65,934 and 1 held positions by 36,563. That puts total institutional holdings at 124,621 shares, according to SEC filings. The stock grabbed 3 new institutional investments totaling 20,876 shares while 5 institutional investors sold out their entire positions totaling 63,934 shares.

Medovex Corporation (NASDAQ:MDVX) Insider Trades

Multiple company employees have indulged in significant insider trading. Medovex Corporation disclosed in a document filed with the US Securities and Exchange Commission (SEC) that Director Haufe Scott has acquired 50,000 shares of Medovex Corporation (MDVX) in trading session dated Apr. 18, 2017. These shares are worth $62,500 and were traded at $1.25 each. The SEC filing shows that Haufe Scott performed a purchase of 250,612 shares. The Director added these shares by way of transaction on Mar. 28, 2017. The company’s shares were assimilated at $1.29 per share worth to an investment of some $323,289 on account of Haufe Scott.

Director, Haufe Scott, purchased 250,612 common shares of Medovex Corporation (MDVX) in the open market. In a transaction dated Mar. 28, 2017, the shares were bought at an average price of $1.29, giving away a sum of $323,289. After this purchase, 1,038,961 common shares of MDVX are directly owned by the insider, with total stake valued at $1,122,078.

In the transaction dated Feb. 09, 2017, the great number of shares acquired came courtesy the CHIEF EXECUTIVE OFFICER; Gorlin Jarrett S added a total of 67,307 shares at an average price of $1.04, amounting to approximately $69,999. The insider now directly owns 617,172 shares worth $666,546.

SHARE
Previous articleEkso Bionics Holdings, Inc. (NASDAQ:EKSO) added to 6 new portfolios
Next articleFIRST TRUST ADVISORS LP is the biggest holder of Sonus Networks, Inc. (NASDAQ:SONS)